Using the elevated plus maze as a bioassay to assess the effects of naturally occurring and exogenously administered compounds to influence anxiety-related behaviors of mice

Neuromethods

Volumn 42, Issue , 2009, Pages 225-246

  Walf, Alicia A ^a   Frye, Cheryl A ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Affect; Anxiety; Knockout; Mood; Murine; Steroid

Indexed keywords

DIAZEPAM; FLUOXETINE; PLACEBO;

ANIMAL BEHAVIOR; ANIMAL HOUSING; ANXIETY; BIOASSAY; C57BL 6 MOUSE; CALIBRATION; CIRCADIAN RHYTHM; ESTRUS CYCLE; HABITUATION; IMMOBILIZATION; LIGHT DARK CYCLE; LOCOMOTION; MAZE TEST; MENTAL STRESS; MOTIVATION; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TELEVISION CAMERA; TEST RETEST RELIABILITY; VALIDATION PROCESS; VALIDITY; WILD TYPE;

ANIMALIA; MURINAE; MUS; RODENTIA;

EID: 70349838049     PISSN: 08932336     EISSN: 19406045     Source Type: Book Series    
DOI: 10.1007/978-1-60761-303-9_12     Document Type: Review

References (70)

1. Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxietyrelated behavior in rodents. Nat Protoc. 2007;2:322-328
2. Belzung C, Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res. 2001;125:141-149
3. Carobrez AP, Bertoglio LJ. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev. 2005;29:1193-1205
4. Dawson GR, Tricklebank MD. Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol Sci. 1995;16:33-36
5. File SE. Factors controlling measures of anxiety and responses to novelty in the mouse. Behav Brain Res. 2001;125:151-157
6. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav. 1996;54:21-30.
7. Kulkarni SK, Sharma AC. Elevated plusmaze: a novel psychobehavioral tool to measure anxiety in rodents. Methods Find Exp Clin Pharmacol. 1991;13:573-577
8. Rodgers RJ, Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev. 1997;21:801-810.
9. Wahlsten D, Metten P, Phillips TJ, Boehm SL 2nd, Burkhart-Kasch S,Dorow J, Doerksen S, Downing C, Fogarty J, Rodd-Henricks K, Hen R, McKinnon CS, Merrill CM, Nolte C, Schalomon M, Schlumbohm JP, Sibert JR,Wenger CD, Dudek BC, Crabbe JC. Different data from different labs: lessons from studies of gene-environment interaction. J Neurobiol. 2003;54:283-311.
10. Wall PM, Messier C. Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior. Neurosci Biobehav Rev. 2001;25:275-286
11. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 1985;14:149-167
12. Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 1987;92:180-185
13. File SE, Mabbutt PS, Hitchcott PK. Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology. 1990;102:98-101.
14. Almeida SS, Garcia RA, de Oliveira LM. Effects of early protein malnutrition and repeated testing upon locomotor and exploratory behaviors in the elevated plusmaze. Physiol Behav. 1993;54:749-752
15. Bertoglio LJ, Carobrez AP. Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety. Behav Brain Res. 2000;108:197-203.
16. Bertoglio LJ, Carobrez AP. Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze. Pharmacol Biochem Behav. 2002;73:963-969
17. Bertoglio LJ, Carobrez AP. Behavioral profile of rats submitted to session 1-session 2 in the elevated plus-maze during diurnal/nocturnal phases and under different illumination conditions. Behav Brain Res. 2002;132:135-143
18. Fernandes C, File SE. The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol Biochem Behav. 1996; 54:31-40.
19. Lee C, Rodgers RJ. Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations. Psychopharmacology. 1990;102:507-513
20. Treit D, Menard J, Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav. 1993;44:463-469
21. Espejo EF. Effects of weekly or daily exposure to the elevated plus-maze in male mice. Behav Brain Res 1991;87:233-238.
22. Adamec R, Strasser K, Blundell J, Burton P, McKay DW. Protein synthesis and the mechanisms of lasting change in anxiety induced by severe stress. Behav Brain Res 2006;167:270-286
23. Adamec R, Blundell J, Burton P. Anxiolytic effects of kindling role of anatomical location of the kindling electrode in response to kindling of the right basolateral amygdala. Brain Res. 2004;1024:44-45
24. Frye CA, Petralia SM, Rhodes ME. Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3-,5--THP. Pharmacol Biochem Behav. 2000;67:587-596.
25. Frye CA, Walf AA, Rhodes ME, Harney JP. Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5 alpha-reductase. Brain Res. 2004;1004:116-124
26. Frye CA, Koonce CJ, Edinger KL, Osborne DM, Walf AA. Androgens with activity at estrogen receptor beta have anxiolytic and cognitive-enhancing effects in male rats and mice. Horm Behav. 2008;54:726-734.
27. Walf AA, Frye CA. Estradiol's effects to reduce anxiety and depressive behavior may be mediated by estradiol dose and restraint stress. Neuropsychopharmacology. 2005; 30:1288-1301
28. Walf AA, Frye CA. Estradiol or diarylpropionitrile decrease anxiety-like behavior of wildtype, but not estrogen receptor b knockout, mice. Behav Neurosci. 2008;122:974-981
29. Hendrie CA, Eilam D, Weiss SM. Effects of diazepam and buspirone on the behaviour of wild voles (Microtus socialis) in two models of anxiety. Pharmacol. Biochem Behav. 1997;58:573-576
30. Holmes A, Parmigiani S, Ferrari PF, Palanza P, Rodgers RJ. Behavioral profile of wild mice in the elevated plus-maze test for anxiety. Physiol Behav. 2000;71:509-516
31. Rex A, Marsden CA, Fink H. Effect of diazepam on cortical 5-HT release and behaviour in the guinea-pig on exposure to the elevated plus maze. Psychopharmacology. 1993;110:490-496
32. Stowe JR, Liu Y, Curtis JT, Freeman ME, Wang Z. Species differences in anxietyrelated responses in male prairie and meadow voles: the effects of social isolation. Physiol Behav. 2005;86:369-378
33. Rodgers RJ, Cole JC. Influence of social isolation, gender, strain, and prior novelty on plus-maze behaviour in mice. Physiol Behav. 1993;54:729-736
34. Montgomery KC. The relation between fear induced by novel stimulation and exploratory behavior. J Comp Physiol Psychol. 1958;48:254-260.
35. Handley SL, Mithani S. Effects of --adrenoreceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn-Schmeideberg's Arch Pharmacol. 1984;327:1-5.
36. Barnett SA. The Rat- A Study in Behavior. University Chicago Press. (1975).
37. Frye CA, Sumida K, Dudek BC, Harney JP, Lydon JP, O'Malley BW, Pfaff DW, Rhodes ME. Progesterone's effects to reduce anxiety behavior of aged mice do not require actions via intracellular progestin receptors. Psychopharmacology. 2006;186:312-322
38. Augustsson H, Dahlborn K, Meyerson BJ. Exploration and risk assessment in female wild house mice (Mus musculus musculus) and two laboratory strains. Physiol Behav. 2005;84:265-277
39. Carola V, D'Olimpio F, Brunamonti E,Mangia F,Renzi P. Evaluation of the elevated plusmaze and open-field tests for the assessment of anxiety-related behaviour in inbred mice. Behav Brain Res. 2002;134:49-57.
40. Ramos A, Berton O, Mormede P, Chaouloff F. A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav Brain Res. 1997;85:57-69.
41. TrullasR, Skolnick P. Differences in fearmotivated behaviors among inbred mouse strains. Psychopharmacology. 1993;111:323-331
42. Voikar V, Koks S, Vasar E, Rauvala H. Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol Behav. 2001;72:271-281
43. Frick KM, Burlingame LA, Arters JA, Berger- Sweeney J. Reference memory, anxiety and estrous cyclicity in C57BL/6NIA mice are affected by age and sex. Neuroscience. 2000;95:293-307.
44. Frye CA, Edinger K, Sumida K. Androgen administration to aged male mice increases anti-anxiety behavior and enhances cognitive performance. Neuropsychopharmacology. 2008;33:1049-1061
45. Seeman MV. Psychopathology in women and men: focus on female hormones. Am J Psychiatry. 1997;154:1641-1647
46. Bothe GW, Bolivar VJ, Vedder MJ, Geistfeld JG. Behavioral differences among fourteen inbred mouse strains commonly used as disease models. Comp Med. 2005;55:326-334
47. Bothe GW, Bolivar VJ, Vedder MJ, Geistfeld JG. Genetic and behavioral differences among five inbred mouse strains commonly used in the production of transgenic and knockout mice. Genes Brain Behav. 2004;3:149-157
48. Hunt C, Hambly C. Faecal corticosterone concentrations indicate that separately housed male mice are not more stressed than group housed males. Physiol Behav. 2006;87:519-526
49. Zhu SW, Yee BK, Nyffeler M, Winblad B, Feldon J, Mohammed AH. Influence of differential housing on emotional behaviour and neurotrophin levels in mice. Behav Brain Res. 2006;169:10-20.
50. Andrade MM, Tome MF, Santiago ES, Lucia-Santos A, de Andrade, TG. Longitudinal study of daily variation of rats' behavior in the elevated plus-maze. Physiol Behav. 2003;78:125-133
51. Jones N, King SM. Influence of circadian phase and test illumination on pre-clinical models of anxiety. Physiol Behav. 2001;72:99-106.
52. Crawley JN, Chen T, Puri A, Washburn R, Sullivan TL, Hill JM, Young NB, Nadler JJ, Moy SS, Young LJ, Caldwell HK, Young WS. Social approach behaviors in oxytocin knockout mice: comparison of two independent lines tested in different laboratory environments. Neuropeptides. 2007;41:145-163
53. Mechiel Korte S, De Boer SF. A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze. Eur J Pharmacol. 2003;463:163-175
54. Adamec RE, Shallow T. Lasting effects on rodent anxiety of a single exposure to a cat. Physiol Behav. 1993;54:101-109
55. Andrews N, File SE. Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety. Eur J Pharmacol. 1993;235:109-112
56. Brett RR, Pratt JA. Chronic handling modifies the anxiolytic effect of diazepam in the elevated plus-maze. Eur J Pharmacol. 1990;178:135-138
57. File SE, Andrews N, Wu PY, Zharkovsky A, Zangrossi, H Jr. Modification of chlordiazepoxide's behavioural and neurochemical effects by handling and plusmaze experience. Eur J Pharmacol 1992;218:9-14.
58. Lapin IP. Only controls: effect of handling, sham injection, and intraperitoneal injection of saline on behavior of mice in an elevated plus-maze. J Pharmacol Toxicol Methods. 1995;34:73-77
59. Padovan CM, Guimaraes FS. Restraintinduced hypoactivity in an elevated plusmaze. Braz J Med Biol Res. 2000;33:79-83.
60. Schmitt U, Hiemke C. Strain differences in open-field and elevated plus-maze behavior of rats without and with pretest handling. Pharmacol Biochem Behav. 1998;59:807-811
61. SteenbergenHL,HeinsbroekRP,VanHestA, Van de PollNE. Sex-dependent effects of inescapable shock administration on shuttleboxescape performance and elevated plus-maze behavior. Physiol Behav. 1990;48:571-576
62. Mong JA, Pfaff DW. Hormonal and genetic influences underlying arousal as it drives sex and aggression in animal and human brains. Neurobiol Aging. 2003;24:S83-8.
63. Morgan MA, Pfaff DW. Estrogen's effects on activity, anxiety, and fear in two mouse strains. Behav Brain Res. 2002;132:85-93.
64. Morgan MA, Pfaff DW. Effects of estrogen on activity and fear-related behaviors in mice. Horm Behav. 2001;40:472-482
65. Walf AA, Frye CA. Estradiol decreases anxiety behavior and enhances inhibitory avoidance and gestational stress produces opposite effects. Stress. 2007;10:251-260
66. File SE, Wardill AG. Validity of head-dipping as a measure of exploration in a modified hole-board. Psychopharmacologia. 1975;44:53-59
67. File SE, Wardill AG. The reliability of the hole-board apparatus. Psychopharmacologia. 1975;44:47-51.
68. Cao BJ, Rodgers, RJ. Dopamine D4 receptor and anxiety: behavioural profiles of clozapine, L-745,870 and L-741,742 in the mouse plus-maze. Eur J Pharmacol. 1997;335:117-125.
69. Lamberty Y, Gower AJ. Arm width and brightness modulation of spontaneous behaviour of two strains of mice tested in the elevated plus-maze. Physiol Behav. 1996;59:439-444
70. Holmes A, Rodgers RJ. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci Biobehav Revs. 1999;23:971-980.